TABLE 1–2 Vaccination Coverage Levels Among Children Aged 19–35 Months, by Selected Vaccines (1995–1999a)

 

1995

1996

1997

1998

1999c

Vaccine/Dose

%

(95% CIb)

%

(95% CI)

%

(95% CI)

%

(95% CI)

%

(95% CI)

DTPd

≥3 Doses

94.7

(±0.6)

95.0

(±0.4)

95.5

(±0.4)

95.6

(±0.5)

95.9

(±0.4)

≥4 Doses

78.5

(±1.0)

81.1

(±0.7)

81.5

(±0.7)

83.9

(±0.8)

84.0

(±0.8)

Poliovirus

≥3 Doses

87.9

(±0.8)

91.1

(±0.5)

90.8

(±0.5)

90.8

(±0.7)

90.0

(±0.6)

Haemophilus influenzae Type b (Hib)

≥3 Doses

91.7

(±0.6)

91.7

(±0.5)

92.7

(±0.5)

93.4

(±0.6)

93.7

(±0.5)

Measle-Containing Vaccine (MCV)

≥1 Doses

89.9

(±0.7)

90.7

(±0.5)

90.5

(±0.5)

92.1

(±0.6)

92.0

(±0.6)

Hepatitis B

≥3 Doses

68.0

(±1.0)

81.8

(±0.7)

83.7

(±0.6)

87.0

(±0.7)

87.9

(±0.7)

Varicella Vaccine

1 Dose

N/Ae

 

16.0

(±0.7)

25.9

(±0.7)

43.2

(±1.0)

52.1

(±1.0)

Combined Series

4 DTP/3 Polio/1 MCVf

76.2

(±1.0)

78.4

(±0.8)

77.9

(±0.7)

80.6

(±0.9)

86.2

(±0.7)

4 DTP/3 Polio/1 MCV/3 Hibg

74.2

(±1.0)

76.5

(±0.8)

76.2

(±0.8)

79.2

(±0.9)

78.8

(±0.9)

aChildren were born during February 1992-May 1994 (1995 survey), February 1993-May 1995 (1996 survey), February 1994-May 1996 (1997 survey), and February 1995–May 1997 (1988 survey).

bCI=confidence interval.

cFirst two quarters of 1999 and last two quarters of 1998. Data can be found at http://www.cdc.gov/nip/.

dDiphtheria and tetanus toxoids and pertussis vaccine/diphtheria and tetanus toxoids.

eNot available; data collection for varicella began in July 1996.

fFour or more doses of DTP/DT, three or more doses of poliovirus vaccine, one or more doses of MCV.

gFour or more doses of DTP/DT, three or more doses of poliovirus vaccine, one or more doses of MCV, and three or more doses of Hib.

SOURCE: Information provided by CDC.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement